Aarti Pharmalabs Limited — Board Meeting, 09-11-2025: Outcome of Board Meeting
09-11-2025 | 03:32 pm
09-11-2025 | 03:32 pm
Aarti Pharmalabs' board approved the consolidated financial results for the quarter and half-year. For Q2 FY26, revenue was ₹418.33 Cr & net profit ₹27.92 Cr (EPS ₹3.08). Note: Consolidated figures include Ganesh Polychem as a JV from April 1, 2025, impacting comparisons.
No comments yet. Be the first to comment!
